Literature DB >> 21293933

Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.

Zhe Sun1, Ying-ying Xu, Zhen-ning Wang, Zhi Zhu, Hao Zhang, Bao-jun Huang, Yan Xu, Jun-qing Chen, Hui-mian Xu.   

Abstract

BACKGROUND: Previous studies revealed serosal invasion as one of the most important predictors of peritoneal micrometastasis. However, even for cancers with serosal invasion, the macroscopic serosal appearance is highly heterogeneous. The aim of the present study was to propose a macroscopic serosal classification (MSC) and to investigate the validity of this classification as a predictor of peritoneal recurrence.
MATERIALS AND METHODS: Clinicopathologic features including MSC of 1528 patients with pT3/pT4a stage gastric cancers who underwent potentially radical surgery were retrospectively reviewed. MSC was classified as reactive type, nodular type, tendonoid type, and color-diffused type according to the macroscopic serosal appearance.
RESULTS: There were significant differences in tumor size, location, Bormann type, Lauren grade, lymphatic and/or blood vessels invasion (LBVI), width of serosa changes, depth of invasion, number of nodes metastasis, lymph node metastasis ratio, pN stage, and peritoneal cytology between patients with different types of serosa. Multivariate analysis revealed MSC, as well as depth of invasion, Lauren grade, and pN stage, significantly predicted the presence of peritoneal-free cancer cells. Both MSC and peritoneal cytology significantly correlated with patient survival. However, only MSC significantly predicted peritoneal recurrence on multivariate analysis, but peritoneal cytology did not, indicating MSC was more sensitive than cytologic examination. Further investigation suggested MSC and pN stage were also independent predictors of peritoneal recurrence for patients with negative peritoneal cytology.
CONCLUSIONS: The MSC sensitively predicts the presence of peritoneal micrometastasis for pT3/pT4a-stage gastric cancer patients who underwent potentially radical surgery. Consequently, it might be considered a good indicator to guide perioperative adjuvant therapy for patients with high risk of peritoneal recurrence.

Entities:  

Mesh:

Year:  2010        PMID: 21293933     DOI: 10.1245/s10434-010-1449-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids obtained pre- and post-lymphadenectomy from gastric cancer patients.

Authors:  Keijiro Sugimura; Yoshiyuki Fujiwara; Takeshi Omori; Masaaki Motoori; Norikatsu Miyoshi; Hirofumi Akita; Kunihito Gotoh; Shogo Kobayashi; Hidenori Takahashi; Shingo Noura; Masayuki Ohue; Takashi Yamamoto; Masato Sakon; Masahiko Yano
Journal:  Surg Today       Date:  2015-08-14       Impact factor: 2.549

2.  Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer.

Authors:  Kenji Nakamura; Kohei Tajima; Kohei Kanamori; Kentaro Yatabe; Mika Ogimi; Tadashi Higuchi; Miho Yamamoto; Hitoshi Hara; Akihito Kazuno; Kazuhito Nabeshima; Eiji Nomura; Kazuo Koyanagi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

3.  The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer.

Authors:  B Zhao; D Mei; J Zhang; S Zou; Hn Lu; H Xu; B Huang
Journal:  Ann R Coll Surg Engl       Date:  2019-01-03       Impact factor: 1.891

4.  Clinical Implication of the Width of Subserosal Invasion in T3N0 Gastric Cancer.

Authors:  Kenji Nakamura; Mifuji Tomioku; Kazuhito Nabeshima; Eiji Nomura
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

5.  Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy.

Authors:  Ju-Hee Lee; Sang-Yong Son; Chang Min Lee; Sang Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  Gastric Cancer       Date:  2013-10-08       Impact factor: 7.370

6.  Macroscopic serosal classification of colorectal cancer and its clinical significance.

Authors:  Yong-Peng Wang; Peng-Tao Guo; Zhi Zhu; Hao Zhang; Yan Xu; Si-Ping Ma; Zhen-Ning Wang; Hui-Mian Xu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Oncologic outcome with use of sodium hyaluronate-carboxymethylcellulose barrier in gastric cancer.

Authors:  Yasuhiko Mohri; Koji Tanaka; Keiichi Uchida; Masaki Ohi; Mikihiro Inoue; Toshimitsu Araki; Yasuhiro Inoue; Masato Kusunoki
Journal:  Int Surg       Date:  2013 Jul-Sep

8.  A New Subclassification of pT4 Gastric Cancers According to the Width of Serosal Invasion.

Authors:  Yue Kang; Feng Wang; Hongliang Zu; Zhenyu Yang; Yingwei Xue
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

9.  Improvement of T stage precision by integration of surgical and pathological staging in radically resected stage pT3-pT4b gastric cancer.

Authors:  Hong-Hu Wang; Kai Li; Hao Xu; Zhe Sun; Zhen-Ning Wang; Hui-Mian Xu
Journal:  Oncotarget       Date:  2017-07-11

10.  Can Preoperative Examination Help Choose the Best Surgical Procedure in Gastric Cancer?

Authors:  Jia-Le Zhang; Zhen-Ning Wang; Hui-Mian Xu; Zhi Zhu; Bao-Jun Huang
Journal:  Gastroenterol Res Pract       Date:  2018-04-01       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.